Wednesday · 2026

Health roundup

14 stories · 14 outlets · 4 min read

AI in Medicare, chronic care, and Alzheimer's

Today's health news is dominated by the messy reality of AI in medicine: a Medicare pilot program is causing patient harm, while a startup raised $100M to automate chronic care. A case report on psilocybin for Alzheimer's offers a glimmer of hope, and a verdict against a brain supplement reminds us that not all 'science' is sound.

In today's edition: AI's mixed record and Promising treatments, plus quick bites.

Techrepublic, Nytimes, Cidrap and 11 more

AI's mixed record

Two stories today capture the double-edged nature of AI in healthcare: one about a government program that's harming patients, the other about a startup that's scaling care.

Promising treatments

A case report on psilocybin for Alzheimer's and a verdict against a memory supplement both touch on brain health, but from very different angles.

truthinadvertising.org · 4 min

0
Jury Hands Down Verdict in Prevagen Deceptive Marketing Case -

A federal jury ruled against Prevagen's maker for deceptive marketing of its memory supplement, ordering removal of all challenged claims. It's a reminder that the supplement industry's promises often outpace the evidence.

Quick bites

Tuesday

23 Jun's edition

Health · 12 stories